Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000070858-26-000526·Inhibrx Biosciences, Inc.
Schedule 13G ownership disclosure
Inhibrx Biosciences Inc
Common Stock · CUSIP: 45720N103
Event date: 2026-09-30
- Filing-level shares
- 357,318.00
- Percent of class
- 2.4%
- BANK OF AMERICA CORP /DE/
Shares: 357,318.00 · Class: 2.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000070858-26-000526
- Form type
- SCHEDULE 13G/A
- Filer
- Inhibrx Biosciences, Inc.
- CIK
- CIK 2007919
- Filed
- Oct 28, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership